Aaron Cowen’s Veradermics MANE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$451M Sell
3,718,970
-450,000
-11% -$49.2M 10.49% 2
2026
Q2
$513M Hold
4,168,970
– – 9.37% 2
2026
Q1
$263M Buy
+4,168,970
New +$210M 6.72% 2

Other funds holding MANE

Aaron Cowen's MANE Position: Q3 2026 in Review

Aaron Cowen reduced its Veradermics (MANE) stake by 11% in Q3 2026, selling an estimated $49.2M and leaving 3,718,970 shares worth $451M. The position accounts for 10.49% of the portfolio, ranked #2.

Aaron Cowen first reported a position in MANE in Q1 2026 and has held it in 3 quarters since. The position peaked at $513M in Q2 2026. 206 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • Aaron Cowen held 3,718,970 shares of Veradermics worth $451M as of Q3 2026.
  • Aaron Cowen sold 450,000 Veradermics shares in Q3 2026, an estimated $49.2M.
  • Veradermics made up 10.49% of Aaron Cowen's portfolio in Q3 2026, its #2 holding.
  • Aaron Cowen first reported a position in Veradermics in Q1 2026 and has held it in 3 quarters since.
  • Aaron Cowen's Veradermics position peaked at $513M in Q2 2026.
  • 206 funds tracked by Wall St. Rank held Veradermics as of Q3 2026.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.